ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $328,578 | +6.0% | 16,036 | +2.8% | 0.00% | 0.0% |
| Q2 2023 | $309,992 | +5.8% | 15,601 | -8.8% | 0.00% | 0.0% |
| Q1 2023 | $293,077 | -2.9% | 17,109 | +11.0% | 0.00% | 0.0% |
| Q4 2022 | $301,691 | +62.2% | 15,416 | +32.6% | 0.00% | +50.0% |
| Q3 2022 | $186,000 | +19.2% | 11,629 | +2.4% | 0.00% | 0.0% |
| Q2 2022 | $156,000 | -6.0% | 11,352 | +8.6% | 0.00% | +100.0% |
| Q1 2022 | $166,000 | -25.9% | 10,452 | +1.7% | 0.00% | -50.0% |
| Q4 2021 | $224,000 | -27.7% | 10,273 | -0.8% | 0.00% | -33.3% |
| Q3 2021 | $310,000 | -29.1% | 10,361 | +4.9% | 0.00% | -25.0% |
| Q2 2021 | $437,000 | +11.5% | 9,874 | +11.7% | 0.00% | +33.3% |
| Q1 2021 | $392,000 | -18.8% | 8,843 | +0.4% | 0.00% | -25.0% |
| Q4 2020 | $483,000 | +131.1% | 8,808 | -3.8% | 0.00% | +100.0% |
| Q3 2020 | $209,000 | – | 9,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |